Overall Technical outlook

Price Summary

On 2026-06-03, NATCO Pharma Limited's shares started at 922.2, peaked at 942.5, bottomed out at 885.4, and ended 1.33% higher at 934.5, with 2605392 shares traded.
For the 52-week period, the stock's highest price is 1206.0, and the lowest price is 792.95.

Technicals

Support and Resistance: The price of 934.5 is supported at 867.5 and capped by resistance at 946.1. These levels mark key points for NATCO Pharma Limited where the price could find stability, with 867.5 as a floor and 946.1 as a ceiling.
NATCOPHARM supportResistance b4d148
Support/Resistance for NATCOPHARM


Aroon: Aroon's bearish trend persists, with Aroon Down staying at the 100 level. This consistent bearish momentum suggests further declines, but a more detailed analysis using other indicators is necessary to confirm the trend's future direction.
NATCOPHARM aroon b4d148
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current price has remained below the lower Bollinger Band since the last move, indicating strong downward pressure in the market. This position suggests that the market may be oversold, with continued bearish momentum expected. The prolonged stay below the band points to a potential continuation of the trend unless a reversal occurs, making it an important factor for traders to consider.
NATCOPHARM bbands b4d148
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR continues to signal a bearish outlook, establishing a resistance level that could act as a ceiling for upward trends. This resistance suggests that the market may struggle to overcome bearish forces, keeping prices under pressure.
NATCOPHARM psar b4d148
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: With the Stochastic K-line under the D-line and below 20, the market shows a mildly bearish trend. This positioning suggests that NATCOPHARM may face some downside risk, though the bearish signal is not particularly strong. Traders should consider this as a cautious indicator.
NATCOPHARM stoch b4d148
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for NATCOPHARM, with no strong trend emerging.
NATCOPHARM trippleSMA b4d148
Tripple SMA chart for NATCO Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.